Literature DB >> 17618076

[Erdheim-Chester disease].

Julien Haroche1, Zahir Amoura, Bertrand Wechsler, Catherine Veyssier-Belot, Frédéric Charlotte, Jean-Charles Piette.   

Abstract

Erdheim-Chester disease is a non-Langerhans cell histiocytosis, classically thought to be rare, but diagnosed more frequently nowadays (250 published cases). Histiocytes of Erdheim-Chester disease are positive for CD68 but not for CD1a, contrary to Langerhans cell histiocytosis. Two signs highly evocative of this diagnosis are nearly constant tracer uptake by the long bones on (99)Tc bone scintigraphy and a "hairy kidney" appearance on abdominal CT scan. A more "elegant" diagnostic method is ultrasound-guided biopsy of the perirenal infiltration. Cardiovascular involvement, which affects the aorta ("coated aorta") as well as all the cardiac layers, leads to one third of the deaths related to this disease. Central nervous system infiltration (especially cerebellar) is severe and difficult to treat. The prognosis is extremely variable and is often worse when there is a cardiovascular and/or central nervous system involvement. The treatment, decided upon on a case-by-case basis at a specialist center, often begins with interferon alpha.

Entities:  

Mesh:

Year:  2007        PMID: 17618076     DOI: 10.1016/j.lpm.2007.04.032

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  9 in total

Review 1.  Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literature.

Authors:  Jose Emilio Sanchez; Carmen Mora; Manuel Macia; Juan F Navarro
Journal:  Int Urol Nephrol       Date:  2010-03-16       Impact factor: 2.370

2.  FDG-PET in the Erdheim-Chester disease: its diagnostic and follow-up role.

Authors:  Emőke Steňová; Boris Steňo; Pavol Povinec; František Ondriaš; Jana Rampalová
Journal:  Rheumatol Int       Date:  2010-12-07       Impact factor: 2.631

Review 3.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

Review 4.  Erdheim-Chester Disease: a Concise Review.

Authors:  Matthias Papo; Jean-François Emile; Thiago Trovati Maciel; Pierre Bay; Alistair Baber; Olivier Hermine; Zahir Amoura; Julien Haroche
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

Review 5.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

6.  Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report.

Authors:  Yeoun Eun Sung; Yoon Seo Lee; Jieun Lee; Kyo Young Lee
Journal:  J Pathol Transl Med       Date:  2017-12-27

7.  A rare case of Erdheim-chester disease reported from Nepal.

Authors:  Sunit Chhetri; Srista Manandhar; Durga Neupane; Sushil Sharma Subedi; Sunny Chhetri; Astha Acharya; Sushant Chaudhary; Pradeep Khatiwada; Suraj Shrestha
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

8.  Erdheim Chester Disease treated successfully with cladribine.

Authors:  Natalya Azadeh; Henry D Tazelaar; Michael B Gotway; Farouk Mookadam; Rafael Fonseca
Journal:  Respir Med Case Rep       Date:  2016-04-04

9.  Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease.

Authors:  Jaume Monmany; Esther Granell; Laura López; Pere Domingo
Journal:  BMJ Case Rep       Date:  2018-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.